30 related articles for article (PubMed ID: 10928471)
1. Cellular uptake of fluvastatin, an inhibitor of HMG-CoA reductase, by rat cultured hepatocytes and human aortic endothelial cells.
Ohtawa M; Masuda N; Akasaka I; Nakashima A; Ochiai K; Moriyasu M
Br J Clin Pharmacol; 1999 Apr; 47(4):383-9. PubMed ID: 10233202
[TBL] [Abstract][Full Text] [Related]
2. Identification of DKK-1 as a novel mediator of statin effects in human endothelial cells.
Pontremoli M; Brioschi M; Baetta R; Ghilardi S; Banfi C
Sci Rep; 2018 Nov; 8(1):16671. PubMed ID: 30420710
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A.
Lakota K; Hrušovar D; Ogrič M; Mrak-Poljšak K; Čučnik S; Tomšič M; Božič B; Žigon P; Sodin-Semrl S
Mediators Inflamm; 2018; 2018():8237209. PubMed ID: 29670468
[TBL] [Abstract][Full Text] [Related]
4. Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression.
Tsai SJ
Oncotarget; 2017 Dec; 8(68):113258-113268. PubMed ID: 29348904
[TBL] [Abstract][Full Text] [Related]
5. Statin Therapy Negatively Impacts Skeletal Muscle Regeneration and Cutaneous Wound Repair in Type 1 Diabetic Mice.
Rebalka IA; Cao AW; Raleigh MJ; Henriksbo BD; Coleman SK; Schertzer JD; Hawke TJ
Front Physiol; 2017; 8():1088. PubMed ID: 29311999
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin Protects from Aβ
Ludka FK; Cunha MP; Dal-Cim T; Binder LB; Constantino LC; Massari CM; Martins WC; Rodrigues ALS; Tasca CI
Mol Neurobiol; 2017 Oct; 54(8):6163-6173. PubMed ID: 27709490
[TBL] [Abstract][Full Text] [Related]
7. Statins as first-line therapy for acute coronary syndrome?
Ostadal P
Exp Clin Cardiol; 2012; 17(4):227-36. PubMed ID: 23592942
[TBL] [Abstract][Full Text] [Related]
8. PAI-1 mediates the TGF-beta1+EGF-induced "scatter" response in transformed human keratinocytes.
Freytag J; Wilkins-Port CE; Higgins CE; Higgins SP; Samarakoon R; Higgins PJ
J Invest Dermatol; 2010 Sep; 130(9):2179-90. PubMed ID: 20428185
[TBL] [Abstract][Full Text] [Related]
9. Statins in the first-line therapy of acute coronary syndrome - similar to aspirin?
Ostadal P; Alan D; Vejvoda J
Exp Clin Cardiol; 2005; 10(1):9-16. PubMed ID: 19641661
[TBL] [Abstract][Full Text] [Related]
10. Fluvastatin: clinical and safety profile.
Corsini A; Jacobson TA; Ballantyne CM
Drugs; 2004; 64(12):1305-23. PubMed ID: 15200346
[TBL] [Abstract][Full Text] [Related]
11. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
Krysiak R; Okopień B; Herman Z
Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease.
Huber K
J Thromb Thrombolysis; 2001 May; 11(3):183-93. PubMed ID: 11577256
[TBL] [Abstract][Full Text] [Related]
13. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells.
Lopez S; Peiretti F; Bonardo B; Juhan-Vague I; Nalbone G
Atherosclerosis; 2000 Oct; 152(2):359-66. PubMed ID: 10998463
[TBL] [Abstract][Full Text] [Related]
14. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells.
Hu XY; Ma YH; Wang C; Yang YH
Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143
[TBL] [Abstract][Full Text] [Related]
15. Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: impact of endotoxin and tumor necrosis factor-alpha.
Muth H; Maus U; Wygrecka M; Lohmeyer J; Grimminger F; Seeger W; Günther A
Crit Care Med; 2004 Jan; 32(1):217-26. PubMed ID: 14707582
[TBL] [Abstract][Full Text] [Related]
16. Biology and facultative secretion of plasminogen activator inhibitor-2.
Belin D
Thromb Haemost; 1993 Jul; 70(1):144-7. PubMed ID: 8236091
[No Abstract] [Full Text] [Related]
17. Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation.
Crick DC; Andres DA; Waechter CJ
Biochem Biophys Res Commun; 1997 Aug; 237(3):483-7. PubMed ID: 9299388
[No Abstract] [Full Text] [Related]
18. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
Mussoni L; Banfi C; Sironi L; Arpaia M; Tremoli E
Thromb Haemost; 2000 Jul; 84(1):59-64. PubMed ID: 10928471
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
